Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
American Journal of Hematology|July 18, 2013
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progressionShang-Ju Wu, Jih-Luh Tang, Chien-Ting Lin, et al.
Blood|January 26, 2010
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutationWen-Chien Chou, Hsin-An Hou, Chien-Yuan Chen, et al.
Blood|August 10, 2010
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutationsWen-Chien Chou, Huai-Hsuan Huang, Hsin-An Hou, et al.
Blood|April 7, 2010
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring systemHsin-An Hou, Tai-Chung Huang, Liang-In Lin, et al.
American Journal of Hematology|April 12, 2014
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
American Journal of Hematology|October 12, 2013
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolutionChien-Chin Lin, Hsin-An Hou, Wen-Chien Chou, et al.
American Journal of Hematology|October 16, 2013
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progressionHsin-An Hou, Yuan-Yeh Kuo, Jih-Luh Tang, et al.
Blood|November 15, 2011
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implicationsHsin-An Hou, Yuan-Yeh Kuo, Chieh-Yu Liu, et al.
Annals of Hematology|September 22, 2014
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolutionHsin-An Hou, Yun-Chu Lin, Yuan-Yeh Kuo, et al.
Blood|August 11, 2011
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogeneticsWen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, et al.
Pageof 9